Our Priorities Supporting Patients and Consumers
Abbott was founded with the purpose of improving health care around the world, and we pursue this commitment by working constantly to improve our products and our product manufacturing processes, as well as the systems by which we distribute Abbott products. We also listen closely to our customers and other key stakeholders and use their feedback to help identify which new products are most needed and how we can best improve our product development, manufacturing and distribution practices in a safe and responsible manner.
When concerns arise about any of Abbott’s products or practices, we act quickly and effectively to resolve the issue and communicate effectively with impacted stakeholders. We also work to help educate patients, consumers and health care professionals about using and prescribing our products effectively and appropriately.
We believe that well-informed patients feel more in control of their health and, therefore, are more likely to take the right steps to minimize their risks and manage their illnesses. Abbott provides a wide range of educational programs and materials to aid patients and consumers in the prevention, diagnosis and treatment of many diseases and health conditions. Our educational programs train patient groups as well as physicians and other health care providers in the correct use of our products, and provide ongoing advice to help manage symptoms.
At the same time, we work with doctors and other health care professionals to share epidemiological data, advancements in science and insights from patients that can lead to more customized diagnostic technologies, treatment regimens and patient support materials.
We are working to strengthen our collaboration with patient organizations around the world – to gain deeper insights into patients’ day-to-day needs and challenges across many disease states. Through this understanding, we aim to improve the depth and quality of disease management information; advance quality of care; educate governments and other policymakers; and raise public awareness about the challenges our patients face and the need for expanded access to treatment.
Note: All data reflects Abbott activities in 2012. Some content has been adjusted to remove data specific to AbbVie, which became a separate company on Jan. 1, 2013.